Jaume Pons's most recent trade in Alx Oncology Holdings Inc was a trade of 1,326 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 19 Feb 2025 | 1,326 | 579,388 | - | 1.2 | 1,525 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | PRESIDENT & CSO | 21 Jan 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 30 Dec 2024 | 10,796 | 580,714 | - | 1.6 | 17,060 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Aug 2024 | 1,937 | 591,510 | - | 2.6 | 4,997 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 11 Jul 2024 | 20,000 | 613,447 | - | 1.0 | 19,800 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | 11 Jul 2024 | 20,000 | 144,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 11 Jul 2024 | 20,000 | 593,447 | - | 7.9 | 158,076 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 01 Jul 2024 | 10,758 | 593,447 | - | 5.8 | 62,599 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | 04 Jun 2024 | 20,000 | 164,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 8.43 per share. | 04 Jun 2024 | 20,000 | 604,205 | - | 8.4 | 168,652 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 04 Jun 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | 06 May 2024 | 20,000 | 184,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 15.92 per share. | 06 May 2024 | 20,000 | 604,205 | - | 15.9 | 318,334 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 06 May 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 16 Apr 2024 | 50,000 | 604,205 | - | 14.2 | 710,195 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 16 Apr 2024 | 25,846 | 654,205 | - | 1.0 | 25,588 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | 16 Apr 2024 | 25,846 | 204,433 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 11.15 per share. | 04 Apr 2024 | 20,000 | 628,359 | - | 11.2 | 223,036 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, PRESIDENT & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 648,359 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, President & CSO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 7,179 | 618,359 | - | 15.0 | 107,972 | Common Stock |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, President & CEO | 25 Jul 2023 | 282,000 | 282,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 89,000 | 625,538 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Dr. Jaume Pons, PhD | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 3,208 | 536,538 | - | 7.3 | 23,547 | Common Stock |
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 3,232 | 539,746 | - | 11.1 | 35,779 | Common Stock |
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | 05 Aug 2022 | 244,000 | 244,000 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 74,000 | 542,978 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | 03 Feb 2022 | 12,254 | 6,128 | - | - | Employee Stock Option (right to buy) | ||
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 03 Feb 2022 | 12,254 | 468,978 | - | 1.9 | 23,405 | Common Stock |
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 03 Feb 2022 | 11,900 | 456,724 | - | 1.0 | 11,781 | Common Stock |
| Alx Oncology Holdings Inc | Mr. Jaume Pons, PhD | Director, President & CEO | 03 Feb 2022 | 11,900 | 230,279 | - | - | Employee Stock Option (right to buy) |